Table 2 Surgical outcomes and ICG fluorescence imaging
|  | ICG group (n = 73) | Non-ICG group (n = 114) | p-value |
|---|---|---|---|
Surgical procedure, n (%) | Â | Â | 0.316 |
  HAR | 18 (24.7%) | 33 (28.9%) |  |
  LAR | 45 (61.6%) | 73 (64%) |  |
  ISR | 10 (13.7%) | 8 (7.1%) |  |
Lateral lymph node dissection, n (%) | 8 (10.9%) | 18 (15.8%) | 0.351 |
Operative time, mina | 280 (212, 375) | 333 (268, 441) | 0.008 |
Blood loss, mLa | 11 (0, 81) | 24 (0, 114) | 0.638 |
Diverting stoma, n (%) | 31 (42.4%) | 40 (35.1%) | 0.310 |
Transanal tube, n (%) | 45 (61.6%) | 31 (27.3%) |  < 0.001 |
The perfusion time after ICG injection, secondb | 34 (11, 82) |  −  |  −  |
Revision of proximal transection line, n (%) | 5 (6.8%) |  −  |  −  |
  Distance from the initially planned transection line, cmb | 8 (3, 14) |  −  |  −  |